Zinc-containing Vaginal Moisturizer Gel Improves Postmenopausal Vulvovaginal Symptoms: A Pilot Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Although vaginal estrogen is highly effective in alleviating genitourinary symptoms of menopause (GSM), some women are reluctant to use hormonal treatment. Our aim was to evaluate the effect of a zinc-containing vaginal moisturizer gel on GSM. Methods: Women with GSM were enrolled. Patients were asked to use the vaginal gel daily for 2 weeks. Vaginal Health Index (VHI) was calculated. Visual analogue scale (VAS) was obtained on vaginal pain, dryness, burning, itching, dyspareunia and dysuria before and 2 weeks after the completion of treatment. Vaginal cytology was obtained. Vulvovaginal symptom questionnaire (VSQ- 21) was used to assess subjective symptoms. Results: Thirty-seven women with GSM participated in the study. The VHI improved significantly (mean ± standard deviation, 13 ± 4 before vs. 17 ± 4 after treatment, P < 0.01). The patient reported VAS combined score was significantly lower after the treatment (18 ± 14 before vs. 7 ± 12 after treatment, P < 0.01). The largest improvement occurred in vaginal dryness. The maturation value did not change significantly. There were no signs of inflammation on vaginal cytology. VSQ-21 combined scores also improved significantly (7.9 ± 5.5 before vs. 2.7 ± 3.6 after the intervention, P < 0.01). Side effects were rare and minor. Conclusions: Novel zinc-containing vaginal moisturizer gel significantly improves postmenopausal vulvovaginal symptoms without serious side effects.
Abstract
Objectives: Although vaginal estrogen is highly effective in alleviating genitourinary symptoms of menopause (GSM), some women are reluctant to use hormonal treatment. Our aim was to evaluate the effect of a zinc-containing vaginal moisturizer gel on GSM. Methods: Women with GSM were enrolled. Patients were asked to use the vaginal gel daily for 2 weeks. Vaginal Health Index (VHI) was calculated. Visual analogue scale (VAS) was obtained on vaginal pain, dryness, burning, itching, dyspareunia and dysuria before and 2 weeks after the completion of treatment. Vaginal cytology was obtained. Vulvovaginal symptom questionnaire (VSQ- 21) was used to assess subjective symptoms. Results: Thirty-seven women with GSM participated in the study. The VHI improved significantly (mean ± standard deviation, 13 ± 4 before vs. 17 ± 4 after treatment, P < 0.01). The patient reported VAS combined score was significantly lower after the treatment (18 ± 14 before vs. 7 ± 12 after treatment, P < 0.01). The largest improvement occurred in vaginal dryness. The maturation value did not change significantly. There were no signs of inflammation on vaginal cytology. VSQ-21 combined scores also improved significantly (7.9 ± 5.5 before vs. 2.7 ± 3.6 after the intervention, P < 0.01). Side effects were rare and minor. Conclusions: Novel zinc-containing vaginal moisturizer gel significantly improves postmenopausal vulvovaginal symptoms without serious side effects.
참고문헌 (19)
- Weber MA, "Assessment of vaginal atrophy : a review", Int Urogynecol J, 26, pp.15~28 (2015)
- Bachmann GA, "Diagnosis and treatment of atrophic vaginitis", Am Fam Physician, 61, pp.3090~3096 (2000)
- Levine KB, "Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women", Menopause, 15, pp.661~666 (2008)
- Nappi RE, "Women’s voices in the menopause : results from an international survey on vaginal atrophy", Maturitas, 67, pp.233~238 (2010)
- Fatemeh Shobeiri, "Quality of Life in Postmenopausal Women in Iran: A Population-based Study", 대한폐경학회지, 22(1), pp.31~38 (2016), 대한폐경학회
- Gandhi J, "Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management", Am J Obstet Gynecol, 215, pp.704~711 (2016)
- 김현경, "The Recent Review of the Genitourinary Syndrome of Menopause", 대한폐경학회지, 21(2), pp.65~71 (2015), 대한폐경학회
- Management of symptomatic vulvovaginal atrophy, "2013position statement of The North American Menopause Society", Menopause, 20, pp.888~902 (2013)
- Takacs P, "The effects of PPARδ agonist and zinc on ovariectomized rats’ vagina", Female Pelvic Med Reconstr Surg, 19, pp.126~131 (2013)
- Takacs P, "Effects of PPAR-delta agonist and zinc on vaginal smooth muscle cells collagen and tropoelastin production", Int Urogynecol J, 23, pp.1775~1779 (2012)
- Taneja SK, "Pathology of ovary, uterus, vagina and gonadotrophs of female mice fed on Zn-deficient diet", Indian J Exp Biol, 28, pp.1058~1065 (1990)
- Erekson EA, "The Vulvovaginal Symptoms Questionnaire : a questionnaire for measuring vulvovaginal symptoms in postmenopausal women", Menopause, 20, pp.973~979 (2013)
- Bachmann G, "Treatment of the postmenopausal woman" (1994), Raven
- 김석환, "Rejuvenation Using Platelet-rich Plasma and Lipofilling for Vaginal Atrophy and Lichen Sclerosus", 대한폐경학회지, 23(1), pp.63~68 (2017), 대한폐경학회
- Lee YK, "Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors : a randomized controlled trial", Obstet Gynecol, 117, pp.922~927 (2011)
- Bygdeman M, "Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women", Maturitas, 23, pp.259~263 (1996)
- Nachtigall LE, "Comparative study : replens versus local estrogen in menopausal women", Fertil Steril, 61, pp.178~180 (1994)
- Dezzutti CS, "Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity", PLoS One, 7, pp.e48328~ (2012)
- Houston DMJ, "In vitro permeation and biological activity of punicalagin and zinc(II)across skin and mucous membranes prone to Herpes simplex virus infection", Eur J Pharm Sci, 96, pp.99~106 (2017)